Primary systemic therapy of invasive lobular cancer: Is there a role for chemotherapy?

被引：0
|
作者：
Katz, A. [1 ]
Saad, E. [2 ,3 ]
Porter, R.
Pusztai, L. [4 ]
机构：
[1] Ctr Paulista Oncol & Albert Einstein H, Sao Paulo, Brazil
[2] Dendrix, Sao Paulo, Brazil
[3] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[4] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BREAST | 2007年 / 16卷
关键词：
D O I：
10.1016/S0960-9776(07)70195-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S51 / S52
页数：2
相关论文
共 50 条
  • [21] Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancer
    Chen, Luqi
    Mcintosh, Stuart A.
    Tyagi, Siddharth
    Dodwell, David
    BREAST, 2024, 77
  • [22] TUBULO-LOBULAR INVASIVE BREAST-CANCER - VARIANT OF LOBULAR INVASIVE CANCER
    FISHER, ER
    GREGORIO, RM
    REDMOND, C
    FISHER, B
    HUMAN PATHOLOGY, 1977, 8 (06) : 679 - 683
  • [23] Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma
    Saki Nakagawa
    Minoru Miyashita
    Ichiro Maeda
    Atsushi Goda
    Hiroshi Tada
    Masakazu Amari
    Yasuyuki Kojima
    Koichiro Tsugawa
    Yasuyo Ohi
    Yasuaki Sagara
    Miku Sato
    Akiko Ebata
    Narumi Harada-Shoji
    Takashi Suzuki
    Makoto Nakanishi
    Tomohiko Ohta
    Takanori Ishida
    Breast Cancer Research and Treatment, 2024, 204 : 453 - 463
  • [24] Response Rates of Invasive Lobular Cancer in Patients Undergoing Neoadjuvant Endocrine or Chemotherapy
    Jakub, James W.
    Zhang, Wenexia
    Solanki, Malvika
    Yonkus, Jennifer
    Boughey, Judy C.
    Harmsen, Scott
    Giridhar, Karthik, V
    AMERICAN SURGEON, 2023, 89 (02) : 230 - 237
  • [25] Response rates of patients with invasive lobular cancer undergoing neoadjuvant endocrine or chemotherapy
    Giridhar, Karthik
    Zhang, Wenxia
    Solanki, Malvika
    Boughey, Judy
    Yonkus, Jennifer
    Harmsen, William
    Jakub, James
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 195 - 196
  • [26] Synchronous lobular carcinoma in situ and invasive lobular cancer: Marker or precursor for invasive lobular carcinoma
    Wallace, A. S.
    Xiang, D.
    Hockman, L.
    Arya, M.
    Jeffress, J.
    Wang, Z.
    Dale, P. S.
    EJSO, 2014, 40 (10): : 1245 - 1249
  • [27] No Effect of Adjuvant Chemotherapy in Postmenopausal Patients with Invasive Lobular (Mixed) Breast Cancer
    Truin, W.
    Voogd, A.
    Vreugdenhil, G.
    van der Heiden-van der Loo, M.
    Siesling, S.
    Roumen, R.
    CANCER RESEARCH, 2011, 71
  • [28] Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma
    Nakagawa, Saki
    Miyashita, Minoru
    Maeda, Ichiro
    Goda, Atsushi
    Tada, Hiroshi
    Amari, Masakazu
    Kojima, Yasuyuki
    Tsugawa, Koichiro
    Ohi, Yasuyo
    Sagara, Yasuaki
    Sato, Miku
    Ebata, Akiko
    Harada-Shoji, Narumi
    Suzuki, Takashi
    Nakanishi, Makoto
    Ohta, Tomohiko
    Ishida, Takanori
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 204 (03) : 453 - 463
  • [29] Predictive factors associated with invasive lobular breast cancer after neoadjuvant chemotherapy
    Julian, T. B.
    Anderson, S.
    Fourchotte, V.
    Zieger, S.
    Mamounas, E.
    Bear, H.
    Costantino, J.
    Wolmark, N.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 17 - 17
  • [30] Lobular carcinoma in situ and invasive lobular cancer of the breast
    Cocquyt, V
    Van Belle, S
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2005, 17 (01) : 55 - 60
12345